Svelte and ASAHI INTECC to Collaborate on Fixed Wire Stent System; Ideal for Transradial Approach
Svelte Medical Systems, Inc., manufacturers of the unique drug-eluting coronary stent fixed wire Integrated Delivery System (IDS), sometimes called a "stent-on-a-wire," and ASAHI INTECC, the top Japanese maker of guidewires used in interventional procedures, have announced a manufacturing and co-promotion agreement. ASAHI will design and manufacture the wire tip of the Svelte IDS stent, using its latest ACTONE technology, and also will be partnering with Svelte in the stents promotion. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - February 15, 2015 Category: Cardiology Source Type: news
Medtronic Insertable Cardiac Monitors Detect Atrial Fibrillation in Stroke Patients in 'Real-World' Study
Medtronic plc (NYSE: MDT), today announced the results of a new "real-world" study of patients who have had a cryptogenic stroke (stroke of unknown cause), in which the Reveal LINQ™ Insertable Cardiac Monitor (ICM) detected atrial fibrillation in everyday practice at an even greater rate than that found in a recent, rigorously-conducted clinical trial (the CRYSTAL AF Study, which was published in The New England Journal of Medicine). (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - February 12, 2015 Category: Cardiology Source Type: news
Boston Scientific to Distribute Bard's Lutonix Drug-Coated Balloon for Blockages in Leg Arteries
Boston Scientific (NYSE: BSX) and C. R. Bard, Inc. (NYSE: BCR) have announced that Bard's Lutonix® 035 drug-coated balloon will be distributed in the United States by Boston Scientific. The specific terms of the agreement were not disclosed. The Lutonix was the first drug-coated balloon (DCB) approved by the FDA for use in the superficial femoral or popliteal arteries in the leg. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - February 10, 2015 Category: Cardiology Source Type: news
The National Board of Physicians and Surgeons (NBPAS) Expands Certification Program
The National Board of Physicians and Surgeons (NBPAS) has responded to the apology issued to the medical professions earlier this week by the American Board of Internal Medicine (ABIM) about its Maintenance of Certification (MOC) program by expanding its own alternative certification program "to most of the American Board of Medical Specialties (ABMS) non-surgical specialties." (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - February 6, 2015 Category: Cardiology Source Type: news
Medtronic Launches Drug-Coated Balloon for Peripheral Artery Disease in U.S.
Medtronic plc (NYSE: MDT) announced yesterday that its IN.PACT Admiral drug-coated balloon (DCB), approved last month by the FDA, is now available for use in the U.S. The first uses of this new addition to the interventional armamentarium were in New York, Michigan, Arizona, and Louisiana. The IN.PACT Admiral is the second such device approved by the FDA, the first being Bard's Lutonix back in October. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - February 6, 2015 Category: Cardiology Source Type: news
Philips Extends Tender Offer Until February 17 to Acquire Volcano
Royal Philips (NYSE: PHG; AEX: PHIA) and Volcano Corporation (NASDAQ:VOLC) today announced that Philips' indirect wholly owned subsidiary Clearwater Merger Sub, Inc. is extending the expiration date for its previously announced tender offer until 9:00 a.m., Eastern Time, on February 17, 2015, for all outstanding shares of common stock of Volcano for USD 18.00 per Volcano share, without interest, less any applicable withholding of taxes. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - February 6, 2015 Category: Cardiology Source Type: news
Medtronic Gets CE Mark for Larger Sizes of CoreValve
Two larger sizes of the CoreValve Evolut R System are now available in Europe, according to Medtronic plc (NYSE: MDT). Conformité Européene approval (CE Mark) has been granted to these new device sizes of 26mm and 29mm, expanding the range of patients that can be treated with this next generation TAVI platform. These new sizes utilize an extending skirt designed to further promote valve sealing at the annulus in order to reduce paravalvular leak. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - February 5, 2015 Category: Cardiology Source Type: news
ABIM Announces Immediate Changes to MOC Program
Today, the American Board of Internal Medicine (ABIM) announced substantial changes to its Maintenance of Certification (MOC) program and indicated a desire to work more closely with the internal medicine community. ABIM President and CEO Richard J. Baron, MD, reached out to diplomates via e-mail to open a conversation on how to improve MOC. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - February 3, 2015 Category: Cardiology Source Type: news
Philips Extends Tender Offer Period to Acquire Volcano
Royal Philips (NYSE: PHG; AEX: PHIA) and Volcano Corporation (NASDAQ:VOLC) today announced that Philips' indirect wholly owned subsidiary Clearwater Merger Sub, Inc. is extending the expiration date for its previously announced tender offer until 12:00 midnight, Eastern Time, on February 5, 2015 (one minute after 11:59 p.m., Eastern Time, on February 4, 2015) for all outstanding shares of common stock of Volcano for USD 18.00 per Volcano share, without interest, less any applicable withholding of taxes. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - February 2, 2015 Category: Cardiology Source Type: news
FDA Approves Medtronic's Melody Transcatheter Pulmonary Valve
This is a brief overview of information related to FDA's approval to market this product. See the links below to the Summary of Safety and Effectiveness Data (SSED) and product labeling for more complete information on this product, its indications for use, and the basis for FDA's approval. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - January 28, 2015 Category: Cardiology Source Type: news
CoreValve: Survival and Safety Advantages Compared to Open Surgery for Patients with Prior CABG
A new sub-analysis of 226 patients from the CoreValve High Risk Study showed benefits over surgical aortic valve replacement (SAVR) for high risk patients who had received CABG prior to their valve replacement procedure. The primary endpoint of all-cause mortality or major stroke at one-year was 11.4% in the TAVR group vs. 21.8% for SAVR group, and reached significance with a p value of 0.04. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - January 28, 2015 Category: Cardiology Source Type: news
Medtronic Completes Acquisition of Covidien
Medtronic plc (NYSE: MDT), a global leader in medical technology, services and solutions, announced today that it has successfully completed the previously announced acquisition of Covidien plc (NYSE: COV). Under the terms of the acquisition agreement, Medtronic, Inc. and Covidien plc are now combined under Medtronic plc. Shares of Medtronic plc are expected to begin trading on the New York Stock Exchange (NYSE) under the symbol "MDT" on Tuesday, January 27, 2015. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - January 26, 2015 Category: Cardiology Source Type: news
Medtronic's Acquisition of Covidien Approved by Irish High Court; Anticipated to Close on January 26, 2015
Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced that the Irish High Court has sanctioned the Covidien scheme of arrangement pursuant to which Medtronic will acquire Covidien under a new holding company incorporated in Ireland to be named Medtronic plc. With the Court's approval of the scheme of arrangement, Medtronic and Covidien anticipate that the transaction, which will result in Medtronic, Inc. and Covidien plc becoming wholly owned subsidiaries of Medtronic plc, will close later today. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - January 26, 2015 Category: Cardiology Source Type: news
Dr. Robert Califf named FDA Deputy Commissioner for Medical Products and Tobacco
U.S. Food and Drug Administration Commissioner Margaret A. Hamburg, M.D., today appointed Robert Califf, M.D., a recognized global leader in cardiology, clinical research, and medical economics, as FDA Deputy Commissioner for Medical Products and Tobacco. In this position, Dr. Califf will provide executive leadership to the Center for Drug Evaluation and Research, the Center for Biologics Evaluation and Research, the Center for Devices and Radiological Healthand the Center for Tobacco Products. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - January 26, 2015 Category: Cardiology Source Type: news
Opsens Fiber Optic System Utilized by FFR Pioneers in Europe and Japan
Opsens Inc. (TSXV:OPS) recently announced that its innovative entry into the fractional flow reserve (FFR) market, the OptoWire and OptoMonitor, received its first use in Europe. The OptoWire system was granted CE Mark approval back in November. And the first use of this new system was significant in that the operator was one of the "founding fathers" of FFR, Dr. Bernard De Bruyne of the Cardiovascular Center Aalst in Belgium. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - January 21, 2015 Category: Cardiology Source Type: news
